Nirsevimab Under Review for Protection Against RSV for All Infants
Nirsevimab is a long-acting anti-RSV for nirsevimab for the prevention of RSV lower.
Nirsevimab is a long-acting anti-RSV for nirsevimab for the prevention of RSV lower.
Increases seen compared with states where neither recreational nor medical legalization has occurred.
Airsupra is a first-in-class, pressurized metered dose inhaler, fixed-dose combination of albuterol and budesonide.
Actemra (tocilizumab) is an interleukin-6 receptor antagonist.
The AAP outlines 5 tests and procedures commonly ordered in pediatric emergency medicine that clinicians and patients should question.
Which clinical screening markers predict aspirin-exacerbated respiratory disease in patients with chronic rhinosinusitis with nasal polyps?
In addition to worsening asthma, other respiratory disorders, and heart conditions, exposure to wildfire smoke can also compromise immunity in healthy individuals.
Warmer temperatures also mean higher ozone levels, which can affect people with respiratory issues such as asthma, bronchitis, or emphysema.
Coexposure associated with even higher risk than the sum of individual effects.
What respiratory symptoms are associated with transitions to or from e-cigarettes and cigarettes, and how prevalent are these symptoms?